| Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens SL Jongbloed, AJ Kassianos, KJ McDonald, GJ Clark, X Ju, CE Angel, ... Journal of Experimental Medicine 207 (6), 1247-1260, 2010 | 879 | 2010 |
| Modeling prostate cancer: a perspective on transgenic mouse models V Jeet, PJ Russell, A Khatri Cancer and Metastasis Reviews 29 (1), 123-142, 2010 | 56 | 2010 |
| MicroRNA theranostics in prostate cancer precision medicine F Matin, V Jeet, JA Clements, GM Yousef, J Batra Clinical chemistry 62 (10), 1318-1333, 2016 | 31 | 2016 |
| Differential uptake and cross‐presentation of soluble and necrotic cell antigen by human DC subsets MC Chiang, KM Tullett, YS Lee, A Idris, Y Ding, KJ McDonald, ... European journal of immunology 46 (2), 329-339, 2016 | 30 | 2016 |
| A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer F Matin, V Jeet, L Moya, LA Selth, S Chambers, JA Clements, J Batra Scientific reports 8 (1), 1-15, 2018 | 24 | 2018 |
| Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells V Jeet, G Tevz, M Lehman, B Hollier, C Nelson Endocrine-related cancer 21 (5), 723-737, 2014 | 20 | 2014 |
| Emergence of MicroRNAs as key players in cancer cell metabolism S Subramaniam, V Jeet, JA Clements, JH Gunter, J Batra Clinical chemistry 65 (9), 1090-1101, 2019 | 15 | 2019 |
| MicroRNAs in HPV associated cancers: small players with big consequences S Satapathy, J Batra, V Jeet, EW Thompson, C Punyadeera Expert review of molecular diagnostics 17 (7), 711-722, 2017 | 13 | 2017 |
| Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer V Jeet, K Ow, E Doherty, B Curley, PJ Russell, A Khatri The Prostate 68 (5), 548-562, 2008 | 13 | 2008 |
| Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer G Tevz, S McGrath, R Demeter, V Magrini, V Jeet, A Rockstroh, ... Molecular and cellular endocrinology 420, 159-168, 2016 | 12 | 2016 |
| Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer V Jeet, P J Russell, N D Verma, A Khatri Current cancer drug targets 12 (2), 144-163, 2012 | 8 | 2012 |
| MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members including prostate-specific antigen in prostate cancer F Matin, V Jeet, S Srinivasan, AS Cristino, J Panchadsaram, JA Clements, ... Clinical chemistry 65 (6), 771-780, 2019 | 4 | 2019 |
| Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway M Moniruzzaman, R Wang, V Jeet, MA McGuckin, SZ Hasnain International journal of molecular sciences 20 (14), 3468, 2019 | 2 | 2019 |
| Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines MC Sadowski, SJ Mcpherson, A Rockstroh, C Soekmadji, G Tevz, ... BJU International 118 (S1), 34-34, 2016 | 1 | 2016 |
| Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist G Tevz, A Hossain, N Bock, V Jeet, RA Bathgate, ED Williams, M Lehman, ... Bju International 116 (Supplement 1), 36-36, 2015 | 1 | 2015 |
| A biomarker and a therapeutic target: investigating the role of glypican-1 in prostate cancer V Jeet, A Rockstroh, MC Yeh, DH Campbell, BJ Walsh, PJ Russell, ... BJU International 122 (S2), 36-37, 2018 | | 2018 |
| Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1) MC Yeh, BWC Tse, NL Fletcher, ZH Huston, C Stewart, K Sokolowski, ... Bju International 122, 34-35, 2018 | | 2018 |
| Allele specific regulation of PDK1 by miRNAs in prostate cancer S Subramaniam, V Jeet, C Walpole, CC Nelson, JH Gunter, JA Clements, ... BJU International 122 (S2), 36-36, 2018 | | 2018 |
| PDK1 dependent aerobic glycolysis and tumorigenesis in prostate cancer is regulated by miRNAs in an allele dependent manner S Subramaniam, V Jeet, C Walpole, CC Nelson, JH Gunter, JA Clements, ... BJU International 120 (S1), 19-19, 2017 | | 2017 |
| More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer. V Jeet, MC Yeh, DH Campbell, BJ Walsh, PJ Russell, CC Nelson British Journal Of Urology International, 2016 | | 2016 |
